GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $49,000 | -7.5% | 141,000 | +24.2% | 0.00% | -33.3% |
| Q2 2016 | $53,000 | -98.9% | 113,530 | -96.7% | 0.00% | -98.5% |
| Q1 2015 | $4,777,000 | +2142.7% | 3,436,456 | +2338.2% | 0.20% | +2742.9% |
| Q4 2014 | $213,000 | -63.4% | 140,944 | -50.1% | 0.01% | -68.2% |
| Q3 2014 | $582,000 | -28.3% | 282,704 | +6.5% | 0.02% | -37.1% |
| Q2 2014 | $812,000 | -54.1% | 265,350 | -62.5% | 0.04% | -64.6% |
| Q1 2014 | $1,770,000 | – | 708,089 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |